Pipamperone Hydrochloride

盐酸匹泮哌隆

Report date: 2022/07/15 10:16:36
NME

Base Information

Drug NamePipamperone Hydrochloride
Drug Alias NamepipamperonumpipamperonaDipiperonR-3345ANT-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D4 receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptorDopamine D4 receptor
Therapy Area/IndicationsDepressive Disorder, MajorMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesAneurotech BVJohnson & Johnson
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorMental Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN05AD05
Related LinksWikipediaDrugBankKEGG